Press Releases

Press Releases

TFF Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

September 10, 2020

TFF Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

Fierce Pharma: Union, TFF team up to fight COVID-19 with inhaled tapeworm med

August 25, 2020

Fierce Pharma: Union, TFF team up to fight COVID-19 with inhaled tapeworm med

Outsourcing-Pharma.com: TFF, Union Therapeutics join on potential COVID-19 treatment

August 24, 2020

Outsourcing-Pharma.com: TFF, Union Therapeutics join on potential COVID-19 treatment

TFF Pharmaceuticals Reports Second Quarter 2020 Financial and Business Results

August 13, 2020

TFF Pharmaceuticals Reports Second Quarter 2020 Financial and Business Results

TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film Freezing Technology in Combination with niclosamide

August 13, 2020

TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film Freezing Technology in Combination with niclosamide

Austin Statesman: Austin’s TFF Pharmaceuticals raises $25.9M with stock offering

August 11, 2020

Austin Statesman: Austin’s TFF Pharmaceuticals raises $25.9M with stock offering

TFF Pharmaceuticals Announces $25.9 Million in Financing to Further Advance Its Thin Film Freezing Technology Platform

August 11, 2020

TFF Pharmaceuticals Announces $25.9 Million in Financing to Further Advance Its Thin Film Freezing Technology Platform

TFF Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update Conference Call on August 13, 2020

August 4, 2020

TFF Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update Conference Call on August 13, 2020

TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical Trial

July 30, 2020

TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical Trial

TFF Pharmaceuticals Comments on Research on the Re-formulation of Remdesivir to a Dry Powder Form for COVID-19 Antiviral Treatment

July 29, 2020

TFF Pharmaceuticals Comments on Research on the Re-formulation of Remdesivir to a Dry Powder Form for COVID-19 Antiviral Treatment

Displaying 61 - 70 of 100
Top